# The EVERY Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/the-every-company

- Industry: Biotechnology
- Headquarters: Daly City, US
- Website: www.every.com/
- Total disclosed funding: $249M
- Latest round: Series D (Nov 4, 2025)
- Investors on record: 16

## About

Based in the US, Clara Foods Co. dba The EVERY Company focuses on delivering innovative plant-based protein solutions that cater to diverse customer needs, emphasizing sustainability and health in their offerings.The EVERY Company is a provider of plant-based protein solutions, established in 2014 in the US. In November 2025, The EVERY Company raised USD 55 million in series D funding led by returning investor McWin, with participation from other returning investors Rage Capital, Minerva S/A, and SOSV. New investors Main Sequence Ventures, TO VC, Grosvenor, New Agrarian, and other unspecified investors also participated in the round. Its headquarters is located in San Francisco, California. Founders Casimir Rob and Chelsea Kowalk have experience in developing food-related innovations, while CEO Arturo Elizondo leads the company's strategic direction.The EVERY Company specializes in innovative plant-based protein solutions, primarily focusing on its flagship products, EVERY OvoBoost™ and EVERY OvoPro™. EVERY OvoBoost™ is a soluble protein designed to enhance the sensory experience and nutritional profile of beverages and food products, suitable for juices, smoothies, and carbonated drinks. EVERY OvoPro™, a functional egg white protein, mimics conventional eggs, allowing use in various culinary applications. Their products target beverage manufacturers, food producers, and health-conscious consumers in North America and Europe, addressing the demand for vegan and allergen-friendly alternatives.The revenue structure of EVERY Company primarily revolves around B2B transactions with manufacturers and food producers leveraging their proprietary protein technologies. The company engages in partnerships and contracts with various food and beverage brands, providing tailored protein solutions. Revenue is generated through the sale of their trademarked proteins, including EVERY OvoBoost™ and EVERY OvoPro™, as well as collaborations that may involve co-development of new products, including bulk sales agreements ensuring a steady revenue stream across the food industry.The EVERY Company plans to expand its product line with new protein solutions designed to meet evolving consumer preferences, with potential launches in 2024. The company plans to utilize the November 2025 funding to increase its manufacturing capabilities, achieve profitability, and broaden its presence in the egg market, with a special focus on the high-volume bakery sector.

## Funding rounds

- Series D, Nov 4, 2025, $55M — Grosvenor, SOSV, Main Sequence Ventures, Bloom8, McWin, Minerva S/A, TO VC, New Agrarian
- Series C, Nov 3, 2021, $177M — Temasek Holdings, SOSV, Prosus Ventures, Wheatsheaf Group, To Ventures Food, Bloom8, McWin
- Series B, Apr 25, 2019 — Ingredion Incorporated, SOSV, B37 Ventures, IndieBio, Hemisphere Ventures
- Series A, Aug 16, 2016, $15M — SOSV
- Seed, Jul 9, 2015, $1.7M — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed, Series A, Series B, Series C, Series D
- Ingredion Incorporated — Series B
- B37 Ventures (https://capitalatlas.ai/funds/b37-ventures) — Series B
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Series B
- Hemisphere Ventures (https://capitalatlas.ai/funds/hemisphere-ventures) — Series B
- Temasek Holdings — Series C
- Prosus Ventures (https://capitalatlas.ai/funds/prosus-ventures) — Series C
- Wheatsheaf Group (https://capitalatlas.ai/funds/wheatsheaf-group) — Series C
- To Ventures Food — Series C
- Bloom8 (https://capitalatlas.ai/funds/bloom8) — Series C, Series D
- McWin (https://capitalatlas.ai/funds/mcwin) — Series C, Series D
- Grosvenor — Series D
- Main Sequence Ventures (https://capitalatlas.ai/funds/main-sequence-ventures) — Series D
- Minerva S/A — Series D
- TO VC (https://capitalatlas.ai/funds/to-vc) — Series D
- New Agrarian — Series D